Analysis

Biotechnology firm Ocugen has announced a fundamental restructuring of its operations, marking a decisive shift in corporate strategy. The company...

Cleveland-Cliffs Inc. has successfully navigated two significant challenges, potentially paving the way for improved operational and financial stability. The integrated...

Omega Healthcare Investors is demonstrating renewed momentum as two prominent financial institutions significantly raised their price targets for the healthcare...

The investment community is holding its breath as aTyr Pharma shares enter a period of suspended animation. Market attention is...

A potential shift in Federal Reserve policy as early as next week is creating a favorable backdrop for regional banking...

The investment climate surrounding Caribou Biosciences is fraught with tension. As this biotechnology firm pursues groundbreaking medical advancements with its...

Flywire Corporation finds itself in a complex situation, pulled between impressive quarterly performance and mounting legal pressure. The global payments...

Could one therapy transform an underfunded biotech into a market leader? TG Therapeutics is making a compelling case with its...

Despite trading near its annual low, global professional services firm Marsh McLennan is making significant strategic moves to position itself...

Palantir Technologies continues to solidify its position as a critical defense technology provider through two significant new partnerships. The data...